|
||||||||||||
|
||||||||||||
| SafetyAlerts June 6, 2002 Boehringer Ingelheim Pharmaceuticals, Inc. Has Recalled Combivent Inhalation Aerosol The Food and Drug Administration (FDA) said Boehringer Ingelheim Pharmaceuticals, Inc. has recalled Combivent Inhalation Aerosol. PRODUCT Combivent Inhalation Aerosol (ipratropium bromide 18 mcg and albuterol sulfate 103 mcg) 14.7g canister, 200 metered actuations, Rx only. Recall # D-283-2. CODE Lot Numbers: 165090A, Exp. Date May-03 165092A, Exp. Date May-03. RECALLING FIRM/MANUFACTURER Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, by FED EX on May 21, 2002. Firm initiated recall is ongoing. REASON Defective container; inhaler may not fire properly and patients will not receive their full dose of medication. VOLUME OF PRODUCT IN COMMERCE 192,089 units total. DISTRIBUTION Nationwide. |
Send mail to:
Webmaster@COPD-International.com with questions
or comments about this web site.
Copyright © 2002-2004 ----- COPD-International.com
Last modified: